跳到主要內容

Landry Robert E 的 Form 4 申報

Regeneron Pharmaceuticals, Inc.(REGN),2023/2/7 申報

申報編號
0001883850-23-000035
申報時間
2023/2/7
交易日
2023/2/3-2/6
申報延遲
4 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 17 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $115.8 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Landry Robert ECIK 0001585160高階主管(EVP Finance CFO)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/2/3Common StockS賣出處分−739$764.50−$564,965.532,105直接
2023/2/3Common StockM行使選擇權取得+3,000$381.92+$1,145,76035,105直接
2023/2/3Common StockF扣股繳稅處分−2,248$774.29−$1,740,603.9232,857直接
2023/2/6Common StockS賣出處分−51$783.05−$39,935.5532,806直接
2023/2/6Common StockS賣出處分−113$784.27F2−$88,622.5132,693直接
2023/2/6Common StockS賣出處分−78$785.88F3−$61,298.6432,615直接
2023/2/6Common StockS賣出處分−85$786.45F4−$66,848.2532,530直接
2023/2/6Common StockS賣出處分−58$787.47−$45,673.2632,472直接
2023/2/6Common StockS賣出處分−99$788.62F5−$78,073.3832,373直接
2023/2/6Common StockS賣出處分−49$789.05−$38,663.4532,324直接
2023/2/6Common StockS賣出處分−10$790.41−$7,904.132,314直接
2023/2/6Common StockS賣出處分−3$791.00−$2,37332,311直接
2023/2/6Common StockS賣出處分−2$793.33−$1,586.6632,309直接
2023/2/6Common StockS賣出處分−99$794.61F6−$78,666.3932,210直接
2023/2/6Common StockS賣出處分−59$795.41F7−$46,929.1932,151直接
2023/2/6Common StockS賣出處分−18$796.43F8−$14,335.7432,133直接
2023/2/6Common StockS賣出處分−28$797.43−$22,328.0432,105直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2023/2/3Common StockM行使選擇權處分−3,000$0.00$0800直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Represents volume-weighted average price of sales of 113 shares of Company stock on February 6, 2023 at prices ranging from $784.02 to $784.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents volume-weighted average price of sales of 78 shares of Company stock on February 6, 2023 at prices ranging from $785.85 to $785.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents volume-weighted average price of sales of 85 shares of Company stock on February 6, 2023 at prices ranging from $786.03 to $786.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents volume-weighted average price of sales of 99 shares of Company stock on February 6, 2023 at prices ranging from $788.48 to $788.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents volume-weighted average price of sales of 99 shares of Company stock on February 6, 2023 at prices ranging from $794.28 to $794.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents volume-weighted average price of sales of 59 shares of Company stock on February 6, 2023 at prices ranging from $795.26 to $795.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F8

Represents volume-weighted average price of sales of 18 shares of Company stock on February 6, 2023 at prices ranging from $796.35 to $796.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)